title: Safety of formoterol in children and adolescents: experience from asthma clinical trials.
authors.affiliation: King's College Hospital, London, UK. john.price@kch.nhs.uk
authors.forename: J F
authors.initials: JF
authors.lastname: Price
authors.forename: F
authors.initials: F
authors.lastname: Radner
authors.forename: W
authors.initials: W
authors.lastname: Lenney
authors.forename: B
authors.initials: B
authors.lastname: Lindberg
mesh_terms: D000293:Adolescent; D058666:Adrenergic beta-2 Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D001993:Bronchodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D000068759:Formoterol Fumarate; D005938:Glucocorticoids / Q000627:therapeutic use; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents; D004983:Ethanolamines; D005938:Glucocorticoids; D000068759:Formoterol Fumarate